Published in Drug Week, February 10th, 2006
According to recent research from England, "Most patients with breast cancer are likely to benefit from local treatment (surgery and/or radiotherapy). Historically an arbitrary cut-off of 70 years has been widely used, above which women were considered for tamoxifen-only treatment."
"We looked at the proportion of our patients who did not have early surgery for breast cancer to see if this cut-off might have been used too rigidly, resulting in suboptimal treatment of some patients over 70 years of age. A step...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.